CCCC vs WTW · rev $35.6M vs P/E 15, rev $9.93B
C4 Therapeutics Inc (CCCC) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported WTW revenue for 2024-12-31 was $9.93B. Net income was -$88.0M. Revenue was up 4.7% from 2023-12-31 to 2024-12-31. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
CCCC currently screens at market cap $425.7M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the CCCC and WTW stock pages for the full models.
Not investment advice.